Halozyme Therapeutics To Present At The 35th Annual J.P. Morgan Healthcare Conference

SAN DIEGO, Dec. 22, 2016 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO), a biotechnology company developing novel oncology and drug-delivery therapies, will be presenting at the 35th Annual J.P. Morgan Healthcare Conference in San Francisco on Mon., Jan. 9 at 3:00 p.m. PT /...